Letter: Immunoglobulin-resistant delayed hemolytic transfusion reaction treated with rituximab in an adult sickle cell patient

Transfusion

Volumn 53, Issue 3, 2013, Pages 688-689

  Delmonte, Letizia ^a   Cantini, Maurizio ^b   Olivieri, Oliviero ^a   De Franceschi, Lucia ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b AOUI ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HYDROXYUREA; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; RITUXIMAB; MONOCLONAL ANTIBODY;

ABDOMINAL PAIN; ADULT; APHERESIS; BLOOD TRANSFUSION REACTION; BONE PAIN; CASE REPORT; DISEASE SEVERITY; FEVER; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBINURIA; HEPATITIS B; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LETTER; MALE; RETICULOCYTE COUNT; SICKLE CELL ANEMIA; SPLENECTOMY; BLOOD; BLOOD GROUP INCOMPATIBILITY; DRUG EFFECT; DRUG RESISTANCE; ERYTHROCYTE TRANSFUSION; HEMOLYTIC ANEMIA; IMMUNOLOGY;

ADULT; ANEMIA, HEMOLYTIC; ANEMIA, SICKLE CELL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BLOOD GROUP INCOMPATIBILITY; DRUG RESISTANCE; ERYTHROCYTE TRANSFUSION; HUMANS; IMMUNOGLOBULINS; MALE;

EID: 84874927567     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12090     Document Type: Letter

References (6)

1. de Franceschi L, Finco G, Vassanelli A, Zaia B, Ischia S, Corrocher R,. A pilot study on the efficacy of ketorolac plus tramadol infusion combined with erythrocytapheresis in the management of acute severe vaso-occlusive crises and sickle cell pain. Haematologica 2004; 89: 1389-1391.
2. De Franceschi L, Cappellini MD, Olivieri O,. Thrombosis and sickle cell disease. Semin Thromb Hemost 2011; 37: 226-236.
3. Bachmeyer C, Maury J, Parrot A, Bachir D, Stankovic K, Girot R, Lionnet F,. Rituximab as an effective treatment of hyperhemolysis syndrome in sickle cell anemia. Am J Hematol 2010; 85: 91-92.
4. Chadebech P, Habibi A, Nzouakou R, Bachir D, Meunier-Costes N, Bonin P, Rodet M, Chami B, Galacteros F, Bierling P, Noizat-Pirenne F,. Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death. Transfusion 2009; 49: 1785-1792.
5. Noizat-Pirenne F, Bachir D, Chadebech P, Michel M, Plonquet A, Lecron JC, Galacteros F, Bierling P,. Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease. Haematologica 2007; 92: e132-135.
6. de Montalembert M, Dumont MD, Heilbronner C, Brousse V, Charrara O, Pellegrino B, Piguet C, Soussan V, Noizat-Pirenne F,. Delayed hemolytic transfusion reaction in children with sickle cell disease. Haematologica 2011; 96: 801-807.